Skip to main content
Signal8

Hsiung Feng

SEC insider (Form 3/4/5 filer). CIK 0002059159. Director at Senti Biosciences, Inc. (SNTI). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Hsiung Feng has filed insider reports for

  • Senti Biosciences, Inc. (SNTI): Director
Hsiung Feng profile photo

Hsiung Feng

CIK: 0002059159

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Senti Biosciences, Inc. logo
SNTI

Senti Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Senti Biosciences, Inc. logo
    SNTI

    Senti Biosciences, Inc.

    Jun 25, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Senti Biosciences, Inc. logo
    SNTI

    Senti Biosciences, Inc.

    Mar 7, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    43.9K shares-

1-2 of 2